MagnéVie B6® for Burnout

N/A

Waitlist Available

Led By JESSIE HAWKINS, PhD

Research Sponsored by Franklin Health Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Summary

This trial aims to see if a supplement with magnesium and vitamin B6 can reduce anxiety, stress, and burnout in nurses working full-time during the COVID-19 pandemic. The supplement is taken regularly over a period of weeks. Magnesium helps relax muscles and nerves, while vitamin B6 improves mood.

Eligible Conditions

Burnout
Stress
Life Stress

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Scores on the Depression Anxiety Stress Scale (DASS-42), stress sub-score after 8 weeks of intervention as compared to a control group, after controlling for baseline scores.

Secondary study objectives

Number of participants with adverse events.

Scores on the Maslach Burnout Inventory for Health Personnel after 8 weeks of intervention as compared to a control group, after controlling for baseline scores.

Scores on the State-Trait Anxiety Inventory after 8 weeks of intervention as compared to a control group, after controlling for baseline scores.

Other study objectives

Cortisol awakening response after 8 weeks of intervention as compared to a control group after controlling for baseline scores.

Scores on the DASS-42 total, anxiety, and depression sub-scores after 8 weeks of intervention as compared to a control group, after controlling for baseline scores.

Scores on the DASS-42, MBI-HSS, and STAI after 4 weeks of intervention as compared to a control group, after controlling for baseline scores.

+1 more